Cutaneous manifestations of proteus syndrome: correlations with general clinical severity
- PMID: 15313810
- DOI: 10.1001/archderm.140.8.947
Cutaneous manifestations of proteus syndrome: correlations with general clinical severity
Abstract
Background: Proteus syndrome is a rare congenital disorder with progressive asymetric overgrowth of multiple tissues.
Objectives: To determine the range of cutaneous findings in Proteus syndrome and to correlate cutaneous findings with overall disease severity.
Design: A prospective cohort study was performed at the National Institutes of Health, a tertiary referral center.
Patients: Twenty-four consecutive children and adults with Proteus syndrome meeting recent diagnostic criteria.
Interventions: Physical examination, including complete skin examination, and review of medical records.
Main outcome measures: Frequency of skin findings; correlation of skin findings with extracutaneous findings; cluster analysis of findings.
Results: The 24 patients had skin abnormalities: 22 (92%) had lipomas, 21 (88%) had vascular malformations, 20 (83%) had cerebriform connective tissue nevi on the soles of the feet, 16 (67%) had epidermal nevi, 9 (38%) had partial lipohypoplasia, and 5 (21%) had patchy dermal hypoplasia. Some patients had localized alterations in skin pigmentation and hair or nail growth. Patients with a greater number of skin abnormalities tended to have a greater number of extracutaneous abnormalities. The number of abnormalities tended to increase with age up to 8 years.
Conclusions: Patients with Proteus syndrome exhibit a variable but defined assortment of cutaneous findings. The correlation between numbers of cutaneous and extracutaneous is consistent with the postulated mosaic basis for this syndrome.
Comment in
-
The manifold faces of proteus syndrome.Arch Dermatol. 2004 Aug;140(8):1001-2. doi: 10.1001/archderm.140.8.1001. Arch Dermatol. 2004. PMID: 15313819 No abstract available.
Similar articles
-
Evolution of skin lesions in Proteus syndrome.J Am Acad Dermatol. 2005 May;52(5):834-8. doi: 10.1016/j.jaad.2004.12.047. J Am Acad Dermatol. 2005. PMID: 15858474
-
Patchy dermal hypoplasia as a characteristic feature of Proteus syndrome.Arch Dermatol. 1997 Jan;133(1):77-80. Arch Dermatol. 1997. PMID: 9006375
-
[Proteus syndrome with cerebral vascular malformations].Neurologia. 2006 Mar;21(2):88-91. Neurologia. 2006. PMID: 16525914 Spanish.
-
Vascular anomalies in Proteus syndrome.Clin Exp Dermatol. 2004 May;29(3):222-30. doi: 10.1111/j.1365-2230.2004.01513.x. Clin Exp Dermatol. 2004. PMID: 15115498 Review.
-
[Proteus syndrome: Case report of bladder vascular malformation causing massive hematuria].Prog Urol. 2012 Feb;22(2):132-5. doi: 10.1016/j.purol.2011.07.011. Epub 2011 Sep 15. Prog Urol. 2012. PMID: 22284599 Review. French.
Cited by
-
Phenotype and Surgical Treatment in a Case of Proteus Syndrome With Craniofacial and Oral Findings.In Vivo. 2021 May-Jun;35(3):1583-1594. doi: 10.21873/invivo.12415. In Vivo. 2021. PMID: 33910840 Free PMC article.
-
AKT1 gene mutation levels are correlated with the type of dermatologic lesions in patients with Proteus syndrome.J Invest Dermatol. 2014 Feb;134(2):543-546. doi: 10.1038/jid.2013.312. Epub 2013 Jul 24. J Invest Dermatol. 2014. PMID: 23884311 Free PMC article. No abstract available.
-
Molecular heterogeneity of the cerebriform connective tissue nevus in mosaic overgrowth syndromes.Cold Spring Harb Mol Case Stud. 2019 Aug 1;5(4):a004036. doi: 10.1101/mcs.a004036. Print 2019 Aug. Cold Spring Harb Mol Case Stud. 2019. PMID: 31371346 Free PMC article.
-
A mouse model of Proteus syndrome.Hum Mol Genet. 2019 Sep 1;28(17):2920-2936. doi: 10.1093/hmg/ddz116. Hum Mol Genet. 2019. PMID: 31194862 Free PMC article.
-
Effect of AKT1 (p. E17K) Hotspot Mutation on Malignant Tumorigenesis and Prognosis.Front Cell Dev Biol. 2020 Oct 6;8:573599. doi: 10.3389/fcell.2020.573599. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33123537 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources